These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6346848)

  • 21. A comparative study of the activity of a new agent, indapamide, in essential arterial hypertension.
    Hatt PY; Leblond JB
    Curr Med Res Opin; 1975; 3(3):138-44. PubMed ID: 1097194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical efficacy and quality of life with indapamide alone or in combination with beta blockers or angiotensin-converting enzyme inhibitors.
    Athanassiadis DI; Dimopoulos CG; Tsakiris AK; Cokkinos DF; Tourkantonis AA; Toutouzas PK; Boutin B; Guez D
    Am J Cardiol; 1990 May; 65(17):62H-66H. PubMed ID: 2184654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of indapamide versus hydrochlorothiazide on plasma lipids and lipoproteins in hypertensive patients: a direct comparison.
    Spence JD; Huff M; Barnett PA
    Can J Clin Pharmacol; 2000; 7(1):32-7. PubMed ID: 10822211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical evaluation of muzolimine and indapamide during treatment for essential hypertension.
    Kirsten R; Molz KH; Tzonev I; Nelson K
    Z Kardiol; 1985; 74 Suppl 2():66-72. PubMed ID: 4002807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indapamide and atenolol in the treatment of hypertension: double-blind comparative and combination study.
    De Divitiis O; Di Somma S; Petitto M; Fazio S; Ligouri V
    Curr Med Res Opin; 1983; 8(7):493-500. PubMed ID: 6354604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regression of left ventricular hypertrophy in patients with essential hypertension. Results of 6 month treatment with indapamide.
    Curry CL; Robinson H; Brown R; Olivan J; Sami M; Honos G; Ruddy TD; Balazovjech I; Touzek F; Galinier F; Mariani M; de Cordoüe A; Barrandon S; Brault Y; Guez D
    Am J Hypertens; 1996 Aug; 9(8):828-32. PubMed ID: 8862231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of indapamide and hydrochlorothiazide plus amiloride as a third drug in the treatment of arterial hypertension.
    Poulsen L; Friberg M; Noer I; Krusell L; Pedersen OL
    Cardiovasc Drugs Ther; 1989 Apr; 3(2):141-4. PubMed ID: 2487529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of a fixed-dose ACE inhibitor-diuretic combination on ambulatory blood pressure and arterial properties in isolated systolic hypertension.
    Ferguson JM; Minas J; Siapantas S; Komesaroff PA; Sudhir K
    J Cardiovasc Pharmacol; 2008 Jun; 51(6):590-5. PubMed ID: 18520951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Head-to-head comparisons of hydrochlorothiazide with indapamide and chlorthalidone: antihypertensive and metabolic effects.
    Roush GC; Ernst ME; Kostis JB; Tandon S; Sica DA
    Hypertension; 2015 May; 65(5):1041-6. PubMed ID: 25733245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indapamide, a new antihypertensive/diuretic agent, in the treatment of patients with edema.
    Eff J; Bratnick J; Zisblatt M; Vukovich RA; Neiss E
    Clin Ther; 1984; 6(6):778-86. PubMed ID: 6509461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of indapamide SR in the treatment of hypertensive patients with type 2 diabetes.
    Kuo SW; Pei-Dee ; Hung YJ; Hsieh AT; Wu LY; Hsieh CH; He CT; Yang TC; Lian WC
    Am J Hypertens; 2003 Aug; 16(8):623-8. PubMed ID: 12878366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An equivalence study of the safety and efficacy of a fixed-dose combination of perindopril with indapamide versus fixed-dose combinations of captopril with hydrochlorothiazide and enalapril with hydrochlorothiazide in the treatment of hypertension.
    Luccioni R; Sever PS; Di Perri T; Redon J; Laurandin I; Brault Y; Chastang C; Guez D
    J Hypertens; 1995 Dec; 13(12 Pt 2):1847-51. PubMed ID: 8903665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multi-centre clinical investigation of indapamide in the United States: a review.
    Vukovich RA; Zisblatt M; Caruso F; Losi M; Barton J; Schotz WE; Webb E; Eff J; Bronstein R; Neiss ES
    Curr Med Res Opin; 1983; 8 Suppl 3():109-22. PubMed ID: 6352183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Indapamide in the treatment of essential arterial hypertension in the elderly.
    Van Hee W; Thomas J; Brems H
    Postgrad Med J; 1981; 57 Suppl 2():29-33. PubMed ID: 7033944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of indapamide versus hydrochlorothiazide on ventricular and arterial function in patients with hypertension and diabetes: results of a randomized trial.
    Vinereanu D; Dulgheru R; Magda S; Dragoi Galrinho R; Florescu M; Cinteza M; Granger C; Ciobanu AO
    Am Heart J; 2014 Oct; 168(4):446-56. PubMed ID: 25262253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical positioning of indapamide sustained release 1.5mg in management protocols for hypertension.
    Leonetti G
    Drugs; 2000; 59 Suppl 2():27-38; discussion 39-40. PubMed ID: 10678595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indapamide is superior to thiazide in the preservation of renal function in patients with renal insufficiency and systemic hypertension.
    Madkour H; Gadallah M; Riveline B; Plante GE; Massry SG
    Am J Cardiol; 1996 Feb; 77(6):23B-25B. PubMed ID: 8848990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multicentre open trial indapamide in general practice.
    Bowker CH; Murphy MA
    Postgrad Med J; 1981; 57 Suppl 2():53-6. PubMed ID: 7033948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of once daily indapamide and pindolol on blood pressure, plasma aldosterone concentration and plasma renin activity in a general practice setting.
    Chalmers JP; Wing LM; Grygiel JJ; West MJ; Graham JR; Bune AJ
    Eur J Clin Pharmacol; 1982; 22(3):191-6. PubMed ID: 7049706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Arterial hypertension in elderly individuals].
    Ambrosioni E
    Presse Med; 2002 Oct; 31 Spec No 2():S17-20. PubMed ID: 12356000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.